3
2
1

Shandong Regional Traditional Chinese Medicine Stem Cell Healthcare Collaborative Innovation Cooperation Community

Release time:

2021-01-21

Shandong Academy of Traditional Chinese Medicine and Shandong Yinfeng Institute of Life Sciences are working together to create a collaborative innovation and cooperation community between traditional Chinese medicine and stem cell healthcare in the Shandong region. Modern active ingredient extraction technology of traditional Chinese medicine is used to conduct research on stem cell technology and products, creating a healthcare industry with Chinese characteristics.
Shandong Academy of Traditional Chinese Medicine is the only provincial-level scientific research unit of traditional Chinese medicine in our province that integrates scientific research, teaching and development. It is mainly engaged in basic research of traditional Chinese medicine, acupuncture and moxibustion, and traditional Chinese medicine, development and research of new traditional Chinese medicine, and clinical application research of traditional Chinese medicine. At present, it is a co construction unit of the national major new drug innovation platform and a provincial-level joint training base for graduate students. It has key disciplines, key research rooms, three-level laboratories There are 8 national level scientific research platforms, including inheritance studios and traditional Chinese medicine processing technology inheritance bases, as well as 16 provincial-level platforms such as provincial engineering technology research centers, key disciplines, key laboratories, and inheritance studios. They have made outstanding contributions in the research of the "new anti malaria drug artemisinin" and are the legal entities holding artemisinin extraction process patents. The achievement of "artificial musk development and industrialization" completed as an important participating unit won the first prize of National Science and Technology Progress Award in 2016.
Shandong Yinfeng Life Science Research Institute is a scientific research institution dedicated to the research and development of stem cell technology and products, genetic testing products, and deep low-temperature medical technology. We have first-class experts and research teams in the fields of cell biology research and industrialization, as well as national major scientific research projects and achievements. We have accumulated a lot of experience in deep cryogenic medicine, genomics, (stem) cell research and industrialization.
Strategic Cooperation
On January 21, 2021, the signing ceremony for the strategic cooperation between Shandong Academy of Traditional Chinese Medicine and Shandong Yinfeng Institute of Life Sciences in the development of medical care and health was successfully completed. Yu Jingzhi, Secretary of Shandong Academy of Traditional Chinese Medicine, Wang Ping, Vice President, Zhang Wanling, Minister of Propaganda Department of Shandong Medical and Health Industry Association, and Dong Baixiang, Executive Director of Shandong Yinfeng Life Science Research Institute attended the event.

11

双方此次战略合作,共同建立山东区域中医药-干细胞医养健康协同创新合作共同体,运用现代中药活性成分提取技术开展干细胞技术和产品研究,打造具有中国特色的医养健康产业。

11

Frontier Communication and Discussion
More than 30 people, including Wang Ping, Vice President of Shandong Academy of Traditional Chinese Medicine, Wei Benjie, Deputy Director of R&D Department of Yinfeng Biotechnology Group Co., Ltd., Wang Long, General Manager of Health Management Center of Shandong Qilu Stem Cell Engineering Technology Co., Ltd., and Zhang Zhihui, Director of Office of Shandong Yinfeng Life Science Research Institute, as well as experts from various fields, participated in the exchange and discussion. In accordance with the guiding spirit of the Shandong Regional Traditional Chinese Medicine Stem Cell Healthcare Collaborative Innovation Cooperation Community, Four parties jointly studied the innovative theory and clinical treatment plan of sequential stem cells in traditional Chinese medicine, focusing on supporting the foundation and strengthening the body. Attendees reported on the progress of "Synergistic Effects and Combined Clinical Research of Traditional Chinese Medicine and Stem Cells", and conducted expert exchanges and discussions on four feasible solutions. Finally, two collaborative research topics were determined, aiming to achieve complementary advantages between traditional Chinese medicine and emerging stem cell technologies, Translate basic research findings into clinical and public health applications.

11

11

Project Planning and Implementation
Within the framework of strategic planning and under the guidance of expert programs, responsible departments of all parties further refine consultations, establish communication and liaison mechanisms for cooperative projects, establish working groups, and be responsible for the overall planning, coordination, and promotion of cooperative projects. When necessary, sign project cooperation agreements, jointly cultivate composite talents of traditional Chinese medicine and stem cells, jointly establish postdoctoral workstations, and leverage the advantages of both parties, Carry out cutting-edge interdisciplinary biological research on the synergistic stem cell technology of traditional Chinese medicine and traditional Chinese medicine.

Latest developments

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.